Cargando…

Etanercept in juvenile idiopathic arthritis: Who will benefit?

Detalles Bibliográficos
Autores principales: Otten, MH, Prince, FHM, Armbrust, W, ten Cate, R, Hoppenreijs, EPAH, Twilt, M, Koopman-Keemink, Y, Gorter, SL, Dolman, KM, Swart, JF, van den Berg, JM, Wulffraat, NM, van Rossum, MAJ, van Suijlekom-Smit, LWA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194423/
http://dx.doi.org/10.1186/1546-0096-9-S1-O28
_version_ 1782213968964616192
author Otten, MH
Prince, FHM
Armbrust, W
ten Cate, R
Hoppenreijs, EPAH
Twilt, M
Koopman-Keemink, Y
Gorter, SL
Dolman, KM
Swart, JF
van den Berg, JM
Wulffraat, NM
van Rossum, MAJ
van Suijlekom-Smit, LWA
author_facet Otten, MH
Prince, FHM
Armbrust, W
ten Cate, R
Hoppenreijs, EPAH
Twilt, M
Koopman-Keemink, Y
Gorter, SL
Dolman, KM
Swart, JF
van den Berg, JM
Wulffraat, NM
van Rossum, MAJ
van Suijlekom-Smit, LWA
author_sort Otten, MH
collection PubMed
description
format Online
Article
Text
id pubmed-3194423
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31944232011-10-18 Etanercept in juvenile idiopathic arthritis: Who will benefit? Otten, MH Prince, FHM Armbrust, W ten Cate, R Hoppenreijs, EPAH Twilt, M Koopman-Keemink, Y Gorter, SL Dolman, KM Swart, JF van den Berg, JM Wulffraat, NM van Rossum, MAJ van Suijlekom-Smit, LWA Pediatr Rheumatol Online J Oral Presentation BioMed Central 2011-09-14 /pmc/articles/PMC3194423/ http://dx.doi.org/10.1186/1546-0096-9-S1-O28 Text en Copyright ©2011 Otten et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Oral Presentation
Otten, MH
Prince, FHM
Armbrust, W
ten Cate, R
Hoppenreijs, EPAH
Twilt, M
Koopman-Keemink, Y
Gorter, SL
Dolman, KM
Swart, JF
van den Berg, JM
Wulffraat, NM
van Rossum, MAJ
van Suijlekom-Smit, LWA
Etanercept in juvenile idiopathic arthritis: Who will benefit?
title Etanercept in juvenile idiopathic arthritis: Who will benefit?
title_full Etanercept in juvenile idiopathic arthritis: Who will benefit?
title_fullStr Etanercept in juvenile idiopathic arthritis: Who will benefit?
title_full_unstemmed Etanercept in juvenile idiopathic arthritis: Who will benefit?
title_short Etanercept in juvenile idiopathic arthritis: Who will benefit?
title_sort etanercept in juvenile idiopathic arthritis: who will benefit?
topic Oral Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3194423/
http://dx.doi.org/10.1186/1546-0096-9-S1-O28
work_keys_str_mv AT ottenmh etanerceptinjuvenileidiopathicarthritiswhowillbenefit
AT princefhm etanerceptinjuvenileidiopathicarthritiswhowillbenefit
AT armbrustw etanerceptinjuvenileidiopathicarthritiswhowillbenefit
AT tencater etanerceptinjuvenileidiopathicarthritiswhowillbenefit
AT hoppenreijsepah etanerceptinjuvenileidiopathicarthritiswhowillbenefit
AT twiltm etanerceptinjuvenileidiopathicarthritiswhowillbenefit
AT koopmankeeminky etanerceptinjuvenileidiopathicarthritiswhowillbenefit
AT gortersl etanerceptinjuvenileidiopathicarthritiswhowillbenefit
AT dolmankm etanerceptinjuvenileidiopathicarthritiswhowillbenefit
AT swartjf etanerceptinjuvenileidiopathicarthritiswhowillbenefit
AT vandenbergjm etanerceptinjuvenileidiopathicarthritiswhowillbenefit
AT wulffraatnm etanerceptinjuvenileidiopathicarthritiswhowillbenefit
AT vanrossummaj etanerceptinjuvenileidiopathicarthritiswhowillbenefit
AT vansuijlekomsmitlwa etanerceptinjuvenileidiopathicarthritiswhowillbenefit